Holen Sie sich die Stockscreener-App
3.1406
9.28%
-0.3094
Schlusskurs vom Vortag:
$3.45
Offen:
$3.49
24-Stunden-Volumen:
71,042
Relative Volume:
1.58
Marktkapitalisierung:
$137.10M
Einnahmen:
$4.71M
Nettoeinkommen (Verlust:
$-46.77M
KGV:
-1.8703
EPS:
-1.6792
Netto-Cashflow:
$-60.34M
1W Leistung:
-16.31%
1M Leistung:
-29.35%
6M Leistung:
-40.27%
1J Leistung:
-68.86%
1-Tages-Spanne:
$3.12
$3.49
1-Wochen-Bereich:
$3.13
$3.66
52-Wochen-Spanne:
$3.13
$11.87
Nyxoah Sa Stock (NYXH) Company Profile
Compare NYXH vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
3.14 | 150.64M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
472.18 | 170.20B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.34 | 45.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.32 | 38.26B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
230.79 | 33.86B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
41.46 | 33.33B | 28.43B | 1.16B | 1.26B | 1.4457 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2022-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-12-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference - GlobeNewswire
Trading Recap: Will Nyxoah SA benefit from rising consumer demandShare Buyback & Target Return Focused Picks - baoquankhu1.vn
Will Nyxoah SA benefit from rising consumer demandJuly 2025 Gainers & AI Driven Stock Movement Reports - baoquankhu1.vn
Technical Analysis: Does Nyxoah SA have a competitive edgeJuly 2025 Final Week & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Aug Ideas: Can Nyxoah SA sustain its profitabilityPortfolio Growth Summary & Low Drawdown Investment Strategies - baoquankhu1.vn
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 - The Manila Times
Nyxoah SA (NASDAQ:NYXH) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Cantor Fitzgerald Upgrades Nyxoah (NASDAQ:NYXH) to "Strong-Buy" - MarketBeat
Nyxoah (NYXH) Expected to Announce Earnings on Thursday - MarketBeat
Nyxoah SA (NASDAQ:NYXH) Short Interest Down 17.8% in February - MarketBeat
Trading the Move, Not the Narrative: (NYXH) Edition - Stock Traders Daily
Publication relating to transparency notifications - GlobeNewswire
Nyxoah (NYXH) Stock Forecast & Price Target - Investing.com
Nyxoah SA (NYXH) Stock Analysis: Exploring a 149% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Information on the total number of voting rights and shares - GlobeNewswire
EV Market: Should value investors consider CNVSTrade Signal Summary & Stock Market Timing Techniques - baoquankhu1.vn
Macro Review: Can Nyxoah SA expand into new marketsJuly 2025 Update & High Accuracy Investment Signals - baoquankhu1.vn
How The Nyxoah (ENXTBR:NYXH) Story Is Shifting As Assumptions And Risks Are Reworked - Yahoo Finance
What’s Nyxoah SA’s historical returnQuarterly Growth Report & Technical Entry and Exit Tips - mfd.ru
EV Market: Is Nyxoah SA forming bullish engulfing patternsIPO Watch & Weekly Chart Analysis and Guides - baoquankhu1.vn
Nyxoah SA (NYXH) Stock Analysis: Unveiling a 126% Potential Upside in Sleep Apnea Solutions - DirectorsTalk Interviews
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East - Bitget
Sleep apnea patients in Middle East get new implant option in Nyxoah–SSMC deal - Stock Titan
Nyxoah SA (NASDAQ:NYXH) Short Interest Up 29.0% in January - Defense World
(NYXH) Volatility Zones as Tactical Triggers - Stock Traders Daily
Contrasting Hinge Health (NYSE:HNGE) and Nyxoah (NASDAQ:NYXH) - Defense World
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System - MSN
Nyxoah SA (NASDAQ:NYXH) Short Interest Update - MarketBeat
NYXH Technical Analysis & Stock Price Forecast - Intellectia AI
Is Nyxoah SA stock undervalued right nowJuly 2025 Highlights & Weekly Stock Breakout Alerts - mfd.ru
Nyxoah SA (NYXH) Stock Analysis: A Healthcare Innovator with a Promising 138.98% Upside Potential - DirectorsTalk Interviews
Returns Recap: Will Nyxoah SA benefit from AI trendsWeekly Stock Recap & Community Supported Trade Ideas - baoquankhu1.vn
Is Nyxoah SA stock overvalued or fairly pricedJuly 2025 Update & Fast Gain Swing Trade Alerts - mfd.ru
Can Nyxoah SA expand into new marketsTrade Analysis Summary & Daily Profit Maximizing Trade Tips - mfd.ru
What is the long term forecast for Nyxoah SA stockJuly 2025 Sector Moves & High Accuracy Trade Signal Alerts - mfd.ru
Nyxoah's Revenue On The Rise- Will The Stock Wake From Its Slumber? - RTTNews
Guidance Update: Is now the right time to enter Nyxoah SABond Market & Daily Stock Trend Watchlist - baoquankhu1.vn
Price-Driven Insight from (NYXH) for Rule-Based Strategy - Stock Traders Daily
Nyxoah SA (NYXH) Stock Analysis: A 137% Potential Upside In The Healthcare Sector - DirectorsTalk Interviews
Aug PreEarnings: Can Nyxoah SA sustain its profitabilityBear Alert & Expert Approved Trade Ideas - baoquankhu1.vn
Price Action: Should I hold or sell Nyxoah SA now2025 Institutional Moves & AI Driven Stock Movement Reports - baoquankhu1.vn
Ideas Watch: Is now the right time to enter Nyxoah SAQuarterly Trade Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Nyxoah (NASDAQ:NYXH) Shares Down 0.4%Time to Sell? - MarketBeat
Nyxoah (NASDAQ:NYXH) Shares Down 0.4% – Time to Sell? - Defense World
Nyxoah Expands Belgian Manufacturing Hub to Support Global Growth in OSA Therapy - The Globe and Mail
Risk Hedge: Is Nyxoah SA stock a good dividend stockTrade Ideas & Long-Term Growth Plans - mfd.ru
Can Nyxoah SA sustain its profitabilityJuly 2025 Big Picture & AI Powered Buy and Sell Recommendations - mfd.ru
Volume Report: Can Nyxoah SA ride the EV waveQuarterly Portfolio Review & Weekly High Return Forecasts - baoquankhu1.vn
Nyxoah Expands Belgian Manufacturing Capacity to Support Global Growth - Sleep Review
Nyxoah SA (NYXH) Investor Outlook: Exploring a 137.85% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Nyxoah invests in further expanding its Belgian manufacturing capacity to support its worldwide growth - marketscreener.com
Finanzdaten der Nyxoah Sa-Aktie (NYXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.05%
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):